Proacta Company
Proacta is a clinical-stage biopharmaceutical company developing hypoxia-activated ’prodrugs“ for the treatment of cancer.
Headquarters:
La Jolla, California, United States
Total Funding:
$47M
Founded Date:
2004
Investors Number:
7
Investor Type:
N/A
Investment Stage:
N/A
Number Of Exists:
N/A
Technology:
Others
Employee Number:
1-10
Industry:
PharmTech
Last Funding Type:
Debt Financing
Funding Status:
Early Stage Venture